Glomerular Disease in Patients with Acute and Chronic Infections
Author: Meghan E. Sise
View More View Less
  • Department of Nephrology, Massachusetts General Hospital, Boston, Massachusetts
  • 1.

    AIDS JUNPoHa. AIDS Info 2018. Available at: https://aidsinfo.unaids.org/. Accessed March 20, 2020

  • 2.

    Mocroft A, Lundgren JD, Ross M, Fux CA, Reiss P, Moranne O, ; Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study: Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: A prospective international cohort study. Lancet HIV 3: e23e32, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    Guaraldi G, Malagoli A, Calcagno A, Mussi C, Celesia BM, Carli F, : The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: A cross sectional study of people aged 65-74 years and more than 75 years. BMC Geriatr 18: 99, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, ; D:A:D study group; Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRIT study group: Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Med 12: e1001809, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Swanepoel CR, Atta MG, D’Agati VD, Estrella MM, Fogo AB, Naicker S, ; Conference Participants: Kidney disease in the setting of HIV infection: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Kidney Int 93: 545559, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Rao TK, Filippone EJ, Nicastri AD, Landesman SH, Frank E, Chen CK, : Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 310: 669673, 1984 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Sise ME, Lo GC, Goldstein RH, Allegretti AS, Masia R: Case 12-2017 - A 34-year-old man with nephropathy. N Engl J Med 376: 15751585, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Winston JA, Bruggeman LA, Ross MD, Jacobson J, Ross L, D’Agati VD, : Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 344: 19791984, 2001 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Levin ML, Palella F, Shah S, Lerma E, Butter J, Kanwar YS: HIV-associated nephropathy occurring before HIV antibody seroconversion. Am J Kidney Dis 37: E39, 2001 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    Cohen AH, Nast CC: HIV-associated nephropathy: A unique combined glomerular, tubular, and interstitial lesion. Mod Pathol 1: 8797, 1988 PubMed

    • Search Google Scholar
    • Export Citation
  • 11.

    D’Agati V, Suh JI, Carbone L, Cheng JT, Appel G: Pathology of HIV-associated nephropathy: A detailed morphologic and comparative study. Kidney Int 35: 13581370, 1989 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12.

    Bruggeman LA, Dikman S, Meng C, Quaggin SE, Coffman TM, Klotman PE: Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 100: 8492, 1997 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, : APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 22: 21292137, 2011 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14.

    Papeta N, Kiryluk K, Patel A, Sterken R, Kacak N, Snyder HJ, : APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. J Am Soc Nephrol 22: 19911996, 2011 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15.

    Atta MG, Estrella MM, Skorecki KL, Kopp JB, Winkler CA, Wasser WG, : Association of APOL1 genotype with renal histology among black HIV-positive patients undergoing kidney biopsy. Clin J Am Soc Nephrol 11: 262270, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Kasembeli AN, Duarte R, Ramsay M, Mosiane P, Dickens C, Dix-Peek T, : APOL1 risk variants are strongly associated with HIV-associated nephropathy in black South Africans. J Am Soc Nephrol 26: 28822890, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17.

    Fine DM, Wasser WG, Estrella MM, Atta MG, Kuperman M, Shemer R, : APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease. J Am Soc Nephrol 23: 343350, 2012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18.

    Estrella MM, Li M, Tin A, Abraham AG, Shlipak MG, Penugonda S, : The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status. Clin Infect Dis 60: 646652, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19.

    Atta MG, Estrella MM, Kuperman M, Foy MC, Fine DM, Racusen LC, : HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics. Kidney Int 82: 338343, 2012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20.

    Mallipattu SK, Salem F, Wyatt CM: The changing epidemiology of HIV-related chronic kidney disease in the era of antiretroviral therapy. Kidney Int 86: 259265, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21.

    Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD: Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: A 12-year cohort study. AIDS 18: 541546, 2004 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22.

    Lescure FX, Flateau C, Pacanowski J, Brocheriou I, Rondeau E, Girard PM, : HIV-associated kidney glomerular diseases: Changes with time and HAART. Nephrol Dial Transplant 27: 23492355, 2012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 23.

    Berliner AR, Fine DM, Lucas GM, Rahman MH, Racusen LC, Scheel PJ, : Observations on a cohort of HIV-infected patients undergoing native renal biopsy. Am J Nephrol 28: 478486, 2008 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24.

    Koech MK, Owiti MOG, Owino-Ong’or WD, Koskei AK, Karoney MJ, D’Agati VD, : Absence of HIV-associated nephropathy among antiretroviral naive adults with persistent albuminuria in western Kenya. Kidney Int Rep 2: 159164, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25.

    Kudose S, Santoriello D, Bomback AS, Stokes MB, Batal I, Markowitz GS, : The spectrum of kidney biopsy findings in HIV-infected patients in the modern era. Kidney Int 97: 10061016, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26.

    Lucas GM, Ross MJ, Stock PG, Shlipak MG, Wyatt CM, Gupta SK, ; HIV Medicine Association of the Infectious Diseases Society of America: Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 59: e96e138, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27.

    Atta MG, Gallant JE, Rahman MH, Nagajothi N, Racusen LC, Scheel PJ, : Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol Dial Transplant 21: 28092813, 2006 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 28.

    Burns GC, Paul SK, Toth IR, Sivak SL: Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy. J Am Soc Nephrol 8: 11401146, 1997 PubMed

    • Search Google Scholar
    • Export Citation
  • 29.

    Post FA, Campbell LJ, Hamzah L, Collins L, Jones R, Siwani R, : Predictors of renal outcome in HIV-associated nephropathy. Clin Infect Dis 46: 12821289, 2008 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30.

    Bigé N, Lanternier F, Viard JP, Kamgang P, Daugas E, Elie C, : Presentation of HIV-associated nephropathy and outcome in HAART-treated patients. Nephrol Dial Transplant 27: 11141121, 2012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31.

    Razzak Chaudhary S, Workeneh BT, Montez-Rath ME, Zolopa AR, Klotman PE, Winkelmayer WC: Trends in the outcomes of end-stage renal disease secondary to human immunodeficiency virus-associated nephropathy. Nephrol Dial Transplant 30: 17341740, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32.

    Boyle SM, Lee DH, Wyatt CM: HIV in the dialysis population: Current issues and future directions. Semin Dial 30: 430437, 2017 PubMed

  • 33.

    Sawinski D, Forde KA, Locke JE, Cohen JB, Weldon J, Shults J, : Race but not hepatitis C co-infection affects survival of HIV+ individuals on dialysis in contemporary practice. Kidney Int 93: 706715, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 34.

    Stock PG, Barin B, Murphy B, Hanto D, Diego JM, Light J, : Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med 363: 20042014, 2010 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 35.

    Locke JE, Mehta S, Reed RD, MacLennan P, Massie A, Nellore A, : A national study of outcomes among HIV-infected kidney transplant recipients. J Am Soc Nephrol 26: 22222229, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 36.

    Waheed S, Sakr A, Chheda ND, Lucas GM, Estrella M, Fine DM, : Outcomes of renal transplantation in HIV-1 associated nephropathy. PLoS One 10: e0129702, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 37.

    Locke JE, Gustafson S, Mehta S, Reed RD, Shelton B, MacLennan PA, : Survival benefit of kidney transplantation in HIV-infected patients. Ann Surg 265: 604608, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38.

    Muller E, Barday Z, Mendelson M, Kahn D: HIV-positive-to-HIV-positive kidney transplantation: Results at 3 to 5 years. N Engl J Med 372: 613620, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 39.

    Haas M, Kaul S, Eustace JA: HIV-associated immune complex glomerulonephritis with “lupus-like” features: A clinicopathologic study of 14 cases. Kidney Int 67: 13811390, 2005 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 40.

    Foy MC, Estrella MM, Lucas GM, Tahir F, Fine DM, Moore RD, : Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy. Clin J Am Soc Nephrol 8: 15241532, 2013 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 41.

    Global Hepatitis Report 2017. Geneva: World Health Organization 2017. Available at: https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/. Accessed March 20, 2020

  • 42.

    Viral Hepatitis Surveillance - United States, 2017. Centers for Disease Control and Prevention; 2017 November 14, 2019. Available at: https://www.cdc.gov/hepatitis/statistics/2017surveillance/index.htm. Accessed March 20, 2020

  • 43.

    Ferri C, Zignego AL, Pileri SA: Cryoglobulins. J Clin Pathol 55: 413, 2002 PubMed

  • 44.

    Cicardi M, Cesana B, Del Ninno E, Pappalardo E, Silini E, Agostoni A, : Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C. J Viral Hepat 7: 138143, 2000 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 45.

    Rutledge SM, Chung RT, Sise ME: Treatment of hepatitis C virus infection in patients with mixed cryoglobulinemic syndrome and cryoglobulinemic glomerulonephritis. Hemodial Int 22[Suppl 1]: S81S96, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 46.

    D’Amico G, Colasanti G, Ferrario F, Sinico RA: Renal involvement in essential mixed cryoglobulinemia. Kidney Int 35: 10041014, 1989 PubMed

  • 47.

    Trejo O, Ramos-Casals M, García-Carrasco M, Yagüe J, Jiménez S, de la Red G, : Cryoglobulinemia: Study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) 80: 252262, 2001 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 48.

    Pouteil-Noble C, Maiza H, Dijoud F, MacGregor B: Glomerular disease associated with hepatitis C virus infection in native kidneys. Nephrol Dial Transplant 15[Suppl 8]: 2833, 2000 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 49.

    Sinico RA, Winearls CG, Sabadini E, Fornasieri A, Castiglione A, D’Amico G: Identification of glomerular immune deposits in cryoglobulinemia glomerulonephritis. Kidney Int 34: 109116, 1988 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 50.

    D’Amico G: Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis. Kidney Int 54: 650671, 1998 PubMed

  • 51.

    De Vita S, Quartuccio L, Isola M, Mazzaro C, Scaini P, Lenzi M, : A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum 64: 843853, 2012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 52.

    Sneller MC, Hu Z, Langford CA: A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis. Arthritis Rheum 64: 835842, 2012 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 53.

    Kidney Disease: Improving Global Outcomes (CKD-MBD) Update Work Group: KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD. Kidney Int Suppl (2011) 7: 159, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 54.

    Saadoun D, Pol S, Ferfar Y, Alric L, Hezode C, Si Ahmed SN, .: Efficacy and safety of sofosbuvir plus daclatasvir for treatment of HCV-associated cryoglobulinemia vasculitis. Gastroenterology. 2017;153(1):49-52 e5

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 55.

    Emery JS, Kuczynski M, La D, Almarzooqi S, Kowgier M, Shah H, : Efficacy and safety of direct acting antivirals for the treatment of mixed cryoglobulinemia. Am J Gastroenterol 112: 12981308, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 56.

    Jadoul M, Berenguer MC, Doss W, Fabrizi F, Izopet J, Jha V, : Executive summary of the 2018 KDIGO hepatitis C in CKD guideline: Welcoming advances in evaluation and management. Kidney Int 94: 663673, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 57.

    Kidney Disease: Improving Global Outcomes (KDIGO): KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int Suppl Apr: S1S99, 2008 PubMed

    • Search Google Scholar
    • Export Citation
  • 58.

    Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, : Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328: 465470, 1993 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 59.

    Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, : Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330: 751756, 1994 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 60.

    Casato M, Agnello V, Pucillo LP, Knight GB, Leoni M, Del Vecchio S, : Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection. Blood 90: 38653873, 1997 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 61.

    Mazzaro C, Zorat F, Caizzi M, Donada C, Di Gennaro G, Maso LD, : Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: A pilot study. J Hepatol 42: 632638, 2005 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 62.

    Hadziyannis SJ, Sette H Jr, Morgan TR, Balan V, Diago M, Marcellin P, ; PEGASYS International Study Group: Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose. Ann Intern Med 140: 346355, 2004 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 63.

    Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, : Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 46: 33173326, 2002 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 64.

    Dammacco F, Tucci FA, Lauletta G, Gatti P, De Re V, Conteduca V, : Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: A long-term study. Blood 116: 343353, 2010 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 65.

    Quartuccio L, Soardo G, Romano G, Zaja F, Scott CA, De Marchi G, : Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: Efficacy and safety in the absence of steroids. Rheumatology (Oxford) 45: 842846, 2006 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 66.

    Roccatello D, Baldovino S, Rossi D, Mansouri M, Naretto C, Gennaro M, : Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Nephrol Dial Transplant 19: 30543061, 2004 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 67.

    Zaja F, Vianelli N, Sperotto A, Patriarca F, Tani M, Marin L, : Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases. Leuk Lymphoma 44: 19511955, 2003 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 68.

    Sansonno D, De Re V, Lauletta G, Tucci FA, Boiocchi M, Dammacco F: Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood 101: 38183826, 2003 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 69.

    Saadoun D, Resche-Rigon M, Sene D, Perard L, Karras A, Cacoub P: Rituximab combined with peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis. Ann Rheum Dis 67: 14311436, 2008 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 70.

    Cacoub P, Delluc A, Saadoun D, Landau DA, Sene D: Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: Where do we stand? Ann Rheum Dis 67: 283287, 2008 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 71.

    Saadoun D, Resche Rigon M, Sene D, Terrier B, Karras A, Perard L, : Rituximab plus peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia. Blood 116: 326334, quiz 504–505, 2010 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 72.

    Bonacci M, Lens S, Marino Z, Londono MC, Rodriguez-Tajes S, Sanchez-Tapias JM, .: Long-term outcomes of patients with HCV-associated cryoglobulinemic vasculitis after virologic cure. Gastroenterology 155: 311315, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 73.

    Gragnani L, Piluso A, Urraro T, Fabbrizzi A, Fognani E, Petraccia L, : Virological and clinical response to interferon-free regimens in patients with HCV-related mixed cryoglobulinemia: Preliminary results of a prospective pilot study. Curr Drug Targets 18: 772785, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 74.

    Saadoun D, Thibault V, Si Ahmed SN, Alric L, Mallet M, Guillaud C, : Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study. Ann Rheum Dis 75: 17771782, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 75.

    Comarmond C, Garrido M, Pol S, Desbois AC, Costopoulos M, Le Garff-Tavernier M, : Direct-acting antiviral therapy restores immune tolerance to patients with hepatitis C virus-induced cryoglobulinemia vasculitis. Gastroenterology 152: 20522062, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 76.

    Gragnani L, Visentini M, Fognani E, Urraro T, De Santis A, Petraccia L, : Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia. Hepatology 64: 14731482, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 77.

    Sise ME, Bloom AK, Wisocky J, Lin MV, Gustafson JL, Lundquist AL, : Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents. Hepatology 63: 408417, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 78.

    Sollima S, Milazzo L, Peri AM, Torre A, Antinori S, Galli M: Persistent mixed cryoglobulinaemia vasculitis despite hepatitis C virus eradication after interferon-free antiviral therapy. Rheumatology (Oxford) 55: 20842085, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 79.

    Mauro E, Quartuccio L, Ghersetti M, Lenzi M, Gitto S, Andreone P, : Direct acting antiviral (DAA) therapy of HCV, effects on the cryoglobulinemic vasculitis: A multicenter open label study. Dig Liver Dis 49: E32, 2017

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 80.

    Cerretelli G, Gragnani L, Monti M, Arena U, Fognani E, Petraccia L, : Sofosbuvir/ribavirin treatment in patients with genotype 2, hepatitis C virus infection and symptomatic mixed cryoglobulinemia: An interim analysis on safety, efficacy and impact on quality of life. J Hepatol 66: S505, 2017

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 81.

    Diakite M, Hartig-Lavie K, Miailhes P, Pradat P, Uhres AC, Zoulim F, : Benefit of direct-acting antiviral therapy in hepatitis C virus (HCV) monoinfected and HIV-HCV coinfected patients with mixed cryoglobulinemia. J Hepatol 66: S528S529, 2017

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 82.

    Bonacci M, Lens S, Londono MC, Marino Z, Cid MC, Ramos-Casals M, : Virologic, clinical, and immune response outcomes of patients with hepatitis C virus-associated cryoglobulinemia treated with direct-acting antivirals. Clin Gastroenterol Hepatol 15: 575583, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 83.

    Roth D, Nelson DR, Bruchfeld A, Liapakis A, Silva M, Monsour H Jr, : Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): A combination phase 3 study. Lancet 386: 15371545, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 84.

    Gane E, Lawitz E, Pugatch D, Papatheodoridis G, Bräu N, Brown A, : Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment. N Engl J Med 377: 14481455, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 85.

    Lawitz E, Flisiak R, Abunimeh M, Sise ME, Park JY, Kaskas M, : Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection. Liver Int 40: 10321041, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 86.

    Borgia SM, Dearden J, Yoshida EM, Shafran SD, Brown A, Ben-Ari Z, : Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis. J Hepatol 71: 660665, 2019 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 87.

    Roth D, Bloom RD, Molnar MZ, Reese PP, Sawinski D, Sise ME, : KDOQI US commentary on the 2018 KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C. Am J Kidney Dis 75: 665683, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 88.

    Barbieri D, García-Prieto A, Torres E, Verde E, Goicoechea M, Luño J: Mixed cryoglobulinaemia vasculitis after sustained hepatitis C virological response with direct-acting antivirals. Clin Kidney J 12: 362364, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 89.

    Fayed A, El Nokeety MM, Samy Abdelaziz T, Samir HH, Hamza WM, El Shabony T: Incidence and characteristics of de novo renal cryoglobulinemia after direct-acting antivirals treatment in an Egyptian hepatitis C cohort. Nephron 140: 275281, 2018 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 90.

    Sise ME, Wisocky J, Rosales IA, Chute D, Holmes JA, Corapi KM, : Lupus-like immune complex-mediated glomerulonephritis in patients with hepatitis C virus infection treated with oral, interferon-free, direct-acting antiviral therapy. Kidney Int Rep 1: 135143, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 91.

    Hogan JJ, Lim MA, Palmer MB, Bloom RD, Chung RT, Sise ME: Development of proteinuria and focal segmental glomerulosclerosis during direct-acting antiviral therapy for hepatitis C virus infection. Hepatology 66: 658660, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 92.

    Ghosn M, Palmer MB, Najem CE, Haddad D, Merkel PA, Hogan JJ. New-onset hepatitis C virus-associated glomerulonephritis following sustained virologic response with direct-acting antiviral therapy. Clin Nephrol 87: 261266, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 93.

    Kupin WL: Viral-associated GN: Hepatitis C and HIV. Clin J Am Soc Nephrol 12: 13371342, 2017 PubMed

  • 94.

    Stehman-Breen C, Alpers CE, Couser WG, Willson R, Johnson RJ: Hepatitis C virus associated membranous glomerulonephritis. Clin Nephrol 44: 141147, 1995 PubMed

    • Search Google Scholar
    • Export Citation
  • 95.

    Markowitz GS, Cheng JT, Colvin RB, Trebbin WM, D’Agati VD: Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol 9: 22442252, 1998 PubMed

    • Search Google Scholar
    • Export Citation
  • 96.

    Coroneos E, Truong L, Olivero J: Fibrillary glomerulonephritis associated with hepatitis C viral infection. Am J Kidney Dis 29: 132135, 1997 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 97.

    Nasr SH, Valeri AM, Cornell LD, Fidler ME, Sethi S, Leung N, : Fibrillary glomerulonephritis: A report of 66 cases from a single institution. Clin J Am Soc Nephrol 6: 775784, 2011 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 98.

    Matsumoto S, Nakajima S, Nakamura K, Etani Y, Hirai H, Shimizu N, : Interferon treatment on glomerulonephritis associated with hepatitis C virus. Pediatr Nephrol 15: 271273, 2000 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 99.

    Ji F, Li Z, Ge H, Deng H: Successful interferon-α treatment in a patient with IgA nephropathy associated with hepatitis C virus infection. Intern Med 49: 25312532, 2010 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 100.

    You CR, Lee SW, Jang JW, Yoon SK: Update on hepatitis B virus infection. World J Gastroenterol 20: 1329313305, 2014 PubMed

  • 101.

    Sunbul M: Hepatitis B virus genotypes: Global distribution and clinical importance. World J Gastroenterol 20: 54275434, 2014 PubMed

  • 102.

    Combes B, Shorey J, Barrera A, Stastny P, Eigenbrodt EH, Hull AR, : Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet 2: 234237, 1971 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 103.

    Lai KN, Li PK, Lui SF, Au TC, Tam JS, Tong KL, : Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 324: 14571463, 1991 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 104.

    Xie Q, Li Y, Xue J, Xiong Z, Wang L, Sun Z, : Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy. Am J Nephrol 41: 345353, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 105.

    Moon JY, Lee SH: Treatment of hepatitis B virus-associated membranous nephropathy: Lamivudine era versus post-lamivudine era. Korean J Intern Med (Korean Assoc Intern Med) 27: 394396, 2012 PubMed

    • Search Google Scholar
    • Export Citation
  • 106.

    Conjeevaram HS, Hoofnagle JH, Austin HA, Park Y, Fried MW, Di Bisceglie AM: Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa. Gastroenterology 109: 540546, 1995 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 107.

    Lin CY: Treatment of hepatitis B virus-associated membranous nephropathy with recombinant alpha-interferon. Kidney Int 47: 225230, 1995 PubMed

  • 108.

    Chung DR, Yang WS, Kim SB, Yu E, Chung YH, Lee Y, : Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon. Am J Nephrol 17: 112117, 1997 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 109.

    Tang S, Lai FM, Lui YH, Tang CS, Kung NN, Ho YW, : Lamivudine in hepatitis B-associated membranous nephropathy. Kidney Int 68: 17501758, 2005 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 110.

    Khedmat H, Taheri S: Hepatitis B virus-associated nephropathy: An international data analysis. Iran J Kidney Dis 4: 101105, 2010 PubMed

    • Search Google Scholar
    • Export Citation
  • 111.

    Fabrizi F, Dixit V, Martin P: Meta-analysis: Anti-viral therapy of hepatitis B virus-associated glomerulonephritis. Aliment Pharmacol Ther 24: 781788, 2006 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 112.

    Chang TT, Gish RG, de Man R, Gadano A, Sollano J, Chao YC, ; BEHoLD AI463022 Study Group: A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med 354: 10011010, 2006 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 113.

    Wang L, Ye Z, Liang H, Zhang B, Xu L, Feng Z, : The combination of tacrolimus and entecavir improves the remission of HBV-associated glomerulonephritis without enhancing viral replication. Am J Transl Res 8: 15931600, 2016 PubMed

    • Search Google Scholar
    • Export Citation
  • 114.

    Lai KN, Tam JS, Lin HJ, Lai FM: The therapeutic dilemma of the usage of corticosteroid in patients with membranous nephropathy and persistent hepatitis B virus surface antigenaemia. Nephron 54: 1217, 1990 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 115.

    Taskapan H, Oymak O, Dogukan A, Ozbakir O, Utas C: Transformation of hepatitis B virus-related membranous glomerulonephritis to crescentic form. Clin Nephrol 54: 161163, 2000 PubMed

    • Search Google Scholar
    • Export Citation
  • 116.

    Lai FM, Tam JS, Li PK, Lai KN: Replication of hepatitis B virus with corticosteroid therapy in hepatitis B virus related membranous nephropathy. Virchows Arch A Pathol Anat Histopathol 414: 279284, 1989 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 117.

    Michalak T: Immune complexes of hepatitis B surface antigen in the pathogenesis of periarteritis nodosa: A study of seven necropsy cases. Am J Pathol 90: 619632, 1978 PubMed

    • Search Google Scholar
    • Export Citation
  • 118.

    Guillevin L: Infections in vasculitis. Best Pract Res Clin Rheumatol 27: 1931, 2013 PubMed

  • 119.

    Lai KN, Lai FM: Clinical features and the natural course of hepatitis B virus-related glomerulopathy in adults. Kidney Int Suppl 35: S40S45, 1991 PubMed

    • Search Google Scholar
    • Export Citation
  • 120.

    Trepo C, Thivolet J: Hepatitis associated antigen and periarteritis nodosa (PAN). Vox Sang 19: 410411, 1970 PubMed

  • 121.

    Heermann KH, Gerlich WH: Immunology of hepatitis B virus infections. Rheumatol Int 9: 167173, 1989 PubMed

  • 122.

    Trepo C, Guillevin L: Polyarteritis nodosa and extrahepatic manifestations of HBV infection: The case against autoimmune intervention in pathogenesis. J Autoimmun 16: 269274, 2001 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 123.

    Levin S, Graber J, Ehrenwald E, Skeik N: Polyarteritis nodosa-induced pancreaticoduodenal artery aneurysmal rupture. Int J Angiol 24: 6366, 2015 PubMed

    • Search Google Scholar
    • Export Citation
  • 124.

    Guillevin L, Lhote F, Cohen P, Sauvaget F, Jarrousse B, Lortholary O, : Polyarteritis nodosa related to hepatitis B virus: A prospective study with long-term observation of 41 patients. Medicine (Baltimore) 74: 238253, 1995 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 125.

    Hernández-Rodríguez J, Alba MA, Prieto-González S, Cid MC: Diagnosis and classification of polyarteritis nodosa. J Autoimmun 48-49: 8489, 2014 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 126.

    Pagnoux C, Seror R, Henegar C, Mahr A, Cohen P, Le Guern V, ; French Vasculitis Study Group: Clinical features and outcomes in 348 patients with polyarteritis nodosa: A systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 62: 616626, 2010 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 127.

    Guillevin L, Mahr A, Callard P, Godmer P, Pagnoux C, Leray E, ; French Vasculitis Study Group: Hepatitis B virus-associated polyarteritis nodosa: Clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 84: 313322, 2005 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 128.

    De Virgilio A, Greco A, Magliulo G, Gallo A, Ruoppolo G, Conte M, : Polyarteritis nodosa: A contemporary overview. Autoimmun Rev 15: 564570, 2016 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 129.

    Segelmark M, Selga D: The challenge of managing patients with polyarteritis nodosa. Curr Opin Rheumatol 19: 3338, 2007 PubMed

  • 130.

    Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, ; European Vasculitis Study Group: EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68: 310317, 2009 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 131.

    Sun IO, Hong YA, Park HS, Choi SR, Chung BH, Park CW, : Clinical characteristics and treatment of patients with IgA nephropathy and hepatitis B surface antigen. Ren Fail 35: 446451, 2013 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 132.

    Zhou TB, Jiang ZP: Is there an association of hepatitis B virus infection with minimal change disease of nephrotic syndrome? A clinical observational report. Ren Fail 37: 459461, 2015 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 133.

    Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, : Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int 97: 829838, 2020

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 134.

    Nasr SH, Markowitz GS, Stokes MB, Said SM, Valeri AM, D’Agati VD: Acute postinfectious glomerulonephritis in the modern era: Experience with 86 adults and review of the literature. Medicine (Baltimore) 87: 2132, 2008 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 135.

    Sharmin S, Shimizu Y, Hagiwara M, Hirayama K, Koyama A: Staphylococcus aureus antigens induce IgA-type glomerulonephritis in Balb/c mice. J Nephrol 17: 504511, 2004 PubMed

    • Search Google Scholar
    • Export Citation
  • 136.

    Shimizu Y, Sakurai H, Hirayama K, Seki M, Yoh K, Yamagata K, : Staphylococcal cell membrane antigen, a possible antigen in post-methicillin resistant Staphylococcus aureus (MRSA) infection nephritis and IgA nephropathy, exhibits high immunogenic activity that is enhanced by superantigen. J Nephrol 18: 249256, 2005 PubMed

    • Search Google Scholar
    • Export Citation
  • 137.

    Satoskar AA, Molenda M, Scipio P, Shim R, Zirwas M, Variath RS, : Henoch-Schönlein purpura-like presentation in IgA-dominant Staphylococcus infection-associated glomerulonephritis: A diagnostic pitfall. Clin Nephrol 79: 302312, 2013 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 138.

    Nasr SH, Fidler ME, Valeri AM, Cornell LD, Sethi S, Zoller A, : Postinfectious glomerulonephritis in the elderly. J Am Soc Nephrol 22: 187195, 2011 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 139.

    Satoskar AA, Suleiman S, Ayoub I, Hemminger J, Parikh S, Brodsky SV, : Staphylococcus infection-associated GN: Spectrum of IgA staining and prevalence of ANCA in a single-center cohort. Clin J Am Soc Nephrol 12: 3949, 2017 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 140.

    Montseny JJ, Meyrier A, Kleinknecht D, Callard P: The current spectrum of infectious glomerulonephritis: Experience with 76 patients and review of the literature. Medicine (Baltimore) 74: 6373, 1995 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 141.

    Batsford SR, Mezzano S, Mihatsch M, Schiltz E, Rodríguez-Iturbe B: Is the nephritogenic antigen in post-streptococcal glomerulonephritis pyrogenic exotoxin B (SPE B) or GAPDH? Kidney Int 68: 11201129, 2005 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 142.

    Rodríguez-Iturbe B, Batsford S: Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet. Kidney Int 71: 10941104, 2007 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 143.

    Rodriguez-Iturbe B, Musser JM: The current state of poststreptococcal glomerulonephritis. J Am Soc Nephrol 19: 18551864, 2008 PubMed

  • 144.

    Eison TM, Ault BH, Jones DP, Chesney RW, Wyatt RJ: Post-streptococcal acute glomerulonephritis in children: Clinical features and pathogenesis. Pediatr Nephrol 26: 165180, 2011 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 145.

    Lien JW, Mathew TH, Meadows R: Acute post-streptococcal glomerulonephritis in adults: A long-term study. Q J Med 48: 99111, 1979 PubMed

    • Search Google Scholar
    • Export Citation
  • 146.

    Sorger K, Balun J, Hübner FK, Köhler H, Olbing H, Schulz W, : The garland type of acute postinfectious glomerulonephritis: Morphological characteristics and follow-up studies. Clin Nephrol 20: 1726, 1983 PubMed

    • Search Google Scholar
    • Export Citation
  • 147.

    Sorger K, Gessler M, Hübner FK, Köhler H, Olbing H, Schulz W, : Follow-up studies of three subtypes of acute postinfectious glomerulonephritis ascertained by renal biopsy. Clin Nephrol 27: 111124, 1987 PubMed

    • Search Google Scholar
    • Export Citation
  • 148.

    Tejani A, Ingulli E: Poststreptococcal glomerulonephritis: Current clinical and pathologic concepts. Nephron 55: 15, 1990 PubMed

  • 149.

    Fries JW, Mendrick DL, Rennke HG: Determinants of immune complex-mediated glomerulonephritis. Kidney Int 34: 333345, 1988 PubMed

  • 150.

    Dagan R, Cleper R, Davidovits M, Sinai-Trieman L, Krause I: Post-infectious glomerulonephritis in pediatric patients over two decades: Severity-associated features. Isr Med Assoc J 18: 336340, 2016 PubMed

    • Search Google Scholar
    • Export Citation
  • 151.

    Wyatt RJ, Forristal J, West CD, Sugimoto S, Curd JG: Complement profiles in acute post-streptococcal glomerulonephritis. Pediatr Nephrol 2: 219223, 1988 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 152.

    Johnston F, Carapetis J, Patel MS, Wallace T, Spillane P: Evaluating the use of penicillin to control outbreaks of acute poststreptococcal glomerulonephritis. Pediatr Infect Dis J 18: 327332, 1999 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 153.

    Pickering MC, D’Agati VD, Nester CM, Smith RJ, Haas M, Appel GB, : C3 glomerulopathy: Consensus report. Kidney Int 84: 10791089, 2013 PubMed

  • 154.

    Brodsky SV, Nadasdy T, Cassol, C, Satoskar, A: IgA staining patterns differentiate between IgA nephropathy and IgA-dominant infection-associated glomerulonephritis, Kidney Int Rep 5: 909911, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 155.

    Sethi S, Fervenza FC, Zhang Y, Zand L, Meyer NC, Borsa N, : Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement. Kidney Int 83: 293299, 2013 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 156.

    Chauvet S, Berthaud R, Devriese M, Mignotet M, Vieira Martins P, Robe-Rybkine T, : Anti-factor B antibodies and acute postinfectious GN in children. J Am Soc Nephrol 31: 829840, 2020 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 157.

    Moroni G, Pozzi C, Quaglini S, Segagni S, Banfi G, Baroli A, : Long-term prognosis of diffuse proliferative glomerulonephritis associated with infection in adults. Nephrol Dial Transplant 17: 12041211, 2002 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 158.

    Gamble CN, Reardan JB: Immunopathogenesis of syphilitic glomerulonephritis: Elution of antitreponemal antibody from glomerular immune-complex deposits. N Engl J Med 292: 449454, 1975 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 159.

    Hoshino-Shimizu S, De Brito T, Kanamura HY, Canto AL, Silva AO, Campos AR, : Human schistosomiasis: Schistosoma mansoni antigen detection in renal glomeruli. Trans R Soc Trop Med Hyg 70: 492496, 1976 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 160.

    Houba V: Experimental renal disease due to schistosomiasis. Kidney Int 16: 3043, 1979 PubMed

  • 161.

    Silva GBD, Pinto JR, Barros EJG, Farias GMN, Daher EF: Kidney involvement in malaria: An update. Rev Inst Med Trop São Paulo 59: e53, 2017 PubMed

    • Search Google Scholar
    • Export Citation
  • 162.

    Gelman R, Brook G, Green J, Ben-Itzhak O, Nakhoul F: Minimal change glomerulonephritis associated with hydatid disease. Clin Nephrol 53: 152155, 2000 PubMed

    • Search Google Scholar
    • Export Citation
  • 163.

    Ali-Khan Z, Rausch RL: Demonstration of amyloid and immune complex deposits in renal and hepatic parenchyma of Alaskan alveolar hydatid disease patients. Ann Trop Med Parasitol 81: 381392, 1987 PubMed

    • Crossref
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 25 25 25
Full Text Views 64 64 64
PDF Downloads 24 24 24